How OpenAI’s Sam Altman Is Thinking About AGI and Superintelligence in 2025
The OpenAI CEO recently published a blog post reflecting on AI progress, as well as his brief ouster from the company.
Related Articles
Bile acid–induced metabolic changes in the colon promote Enterobacteriaceae expansion and associate with dysbiosis in Crohn’s disease
Bile acids promote Enterobacteriaceae overpopulation by increasing intestinal oxygen availability.
Fish implanted with tumor cells could help oncologists quickly personalize cancer treatments
The first clinical trial of zebrafish embryos acting as cancer “avatars” will start soon
Is obesity a disease? Not always, new expert report says
A more scientific definition of obesity should guide decisions about weight loss treatment, researchers argue
Gene editor may have cured infant of a deadly metabolic disorder
Result could be first success at stitching a curative gene into a chromosome’s “safe harbor,” reducing cancer and other risks
Failure to replicate
A historian confronts the complicated origins and uncertain future of priming research
How moral resilience helps nurses work through ethical strife | Aeon Essays
Nurses experience deep suffering when they can’t act according to their moral compass. Our research shows a way forward
AGI is an Engineering Problem
Until this decade, artificial general intelligence was a scientific problem.
OpenAI has created an AI model for longevity science
OpenAI is making a foray into scientific discovery with an AI built to help manufacture stem cells.
Web3 and the Metaverse: Spaziocrypto’s Take on Virtual Worlds Powered by Blockchain – Publicist Paper
Web3 is a project built on blockchain and cryptocurrency, but it can be multiple metaverses. Although the technologies are intertwined, they have significant differences. At…
AGI is an Engineering Problem
Until this decade, artificial general intelligence was a scientific problem.